About Argenta Discovery
Argenta Discovery is a Healthcare company based in London (United Kingdom) founded in 2000, and was acquired by Charles River Laboratories in February 2010. Preclinical drug testing services are conducted by Argenta Discovery. Its chief executive, as recorded, is Christopher Ashton. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include Gentronix and Aquila BioMedical.
Company details
Argenta Discovery was founded in 2000 and is headquartered in London, United Kingdom. As a contract research organization (CRO), preclinical testing services for drug development are provided to pharmaceutical and biotechnology clients. Operations encompass various assays and models to evaluate compound efficacy and safety. The company is led by CEO Christopher Ashton, with a focus on supporting early-stage research needs.
- Headquarters London, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website argentadiscovery.com
- Acquired by Charles River Laboratories (Feb 2010)
- Investors
- Acquired byCharles River Laboratories
(Feb 2010)
Investors in Argenta Discovery
Argenta Discovery has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Charles River Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of drug discovery and preclinical development services | 1947 | criver.com | Wilmington, United States |
Investor details for Argenta Discovery
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Argenta Discovery
1 people are tracked at Argenta Discovery (1 in leadership).
| Name | Role | Group |
|---|---|---|
Christopher Ashton | CEO | Leadership |
Complete people profiles for Argenta Discovery
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Argenta Discovery
2 dated milestones of Argenta Discovery across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Argenta Discovery is founded.
- Exit Acquired by Charles River Laboratories.
Competitors of Argenta Discovery
Argenta Discovery has 2 listed competitors in our database. They include Gentronix and Aquila BioMedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gentronix.co.uk | 1999 | Alderley Edge, United Kingdom | 1 | In-vitro and in-vivo genetic toxicology screening services are provided. | ||
| aquila-bm.com | 2011 | Edinburgh, United Kingdom | 489 | Preclinical services in immunology, regeneration, neuroscience, and histology are provided. |
Detailed competitors of Argenta Discovery
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Argenta Discovery
Websites that share an audience with Argenta Discovery (argentadiscovery.com).
Websites whose visitors overlap most with Argenta Discovery. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nanotherapeutics.com | nanotherapeutics.com | 100% | – | ||
phytopharm.com | phytopharm.com | 100% | – | ||
kinexpharma.com | kinexpharma.com | 100% | – | ||
| cytomyx.com | 100% | View details | |||
| vicortech.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Argenta Discovery
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Argenta Discovery
Argenta Discovery was founded in 2000.
Argenta Discovery is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Christopher Ashton is the CEO of Argenta Discovery, as recorded in our data.
Argenta Discovery was founded in 2000 and is headquartered in London, United Kingdom. As a contract research organization (CRO), preclinical testing services for drug development are provided to pharmaceutical and biotechnology clients. Operations encompass various assays and models to evaluate compound efficacy and safety. The company is led by CEO Christopher Ashton, with a focus on supporting early-stage research needs.
Argenta Discovery's top competitors include Gentronix and Aquila BioMedical.
Argenta Discovery has 1 investor. Key investors include Charles River Laboratories.
Yes. Argenta Discovery was acquired by Charles River Laboratories in February 2010.